2VU9 | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | BGC, GAL, MG, NGA, SIA | enzyme |
| ||||||||||||
note | 2VU9 is a representative structure | ||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | Crystal structure of botulinum neurotoxin type A in complex with the cell surface co-receptor GT1b-insight into the toxin-neuron interaction., Stenmark P, Dupuy J, Imamura A, Kiso M, Stevens RC, PLoS Pathog. 2008 Aug 15;4(8):e1000129. PMID:18704164 |
Data retrieval |
![]() |
View 2VU9 in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
![]() |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |